Australian M&A and equity raisings
1,881 deals since January 2025, each with its advisers and sources · as at 8 Nov 2026 · Venture rounds
116 deals · A$3.4bndisclosed · Health care · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value A$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| May 2025 | AdAlta | – | – | Entitlement offer | Completed | 1.1 | Biotech and pharmaceuticals | Mahe Capital (lead manager) |
| May 2025 | BlinkLab | – | – | Placement | Completed | 7.7 | Medical devices and technology | Westar Capital (lead manager)Alpine Capital (lead manager) |
| May 2025 | EBR Systems | – | – | Placement | Completed | 62.0 | Medical devices and technology | Johnson Winter Slattery (issuer) |
| Apr 2025 | NeuroScientific Biopharmaceuticals | – | – | Placement | Announced | 3.5 | Biotech and pharmaceuticals | Westar Capital (lead manager) |
| Apr 2025 | Botanix Pharmaceuticals | – | – | Placement | Completed | 40.0 | Biotech and pharmaceuticals | Euroz Hartleys (lead manager)E&P Capital (lead manager) |
| Mar 2025 | The Hydration Pharmaceuticals Company | – | – | Entitlement offer | Completed | 0.6 | Biotech and pharmaceuticals | Evolution Capital (lead manager) |
| Mar 2025 | The Hydration Pharmaceuticals Company | – | – | Placement | Completed | 0.7 | Biotech and pharmaceuticals | Evolution Capital (lead manager) |
| Mar 2025 | Bioxyne | – | – | Placement | Completed | 3.0 | Biotech and pharmaceuticals | Alpine Capital (lead manager) |
| Mar 2025 | Imricor Medical Systems | – | – | Placement | Completed | 70.0 | Medical devices and technology | Morgans (lead manager) |
| Feb 2025 | Arovella Therapeutics | – | – | Placement | Announced | 15.0 | Biotech and pharmaceuticals | Ord Minnett (lead manager)Taylor Collison (lead manager) |
| Feb 2025 | Ryman Healthcare | – | – | Entitlement offer | Announced | – | Hospitals, clinics and aged care | Jarden (lead manager) |
| Feb 2025 | 4DMedical | – | – | Placement | Completed | 13.9 | Medical devices and technology | Bell Potter (lead manager) |
| Feb 2025 | PYC Therapeutics | – | – | Entitlement offer | Completed | 146.0 | Biotech and pharmaceuticals | Tenzing Partners (issuer)E&P Capital (lead manager)Barrenjoey (lead manager) |
| Feb 2025 | Micro-X | – | – | Entitlement offer | Completed | 6.4 | Medical devices and technology | Morgans (lead manager)Hawkesbury Partners (lead manager) |
| Jan 2025 | Nova Eye Medical | – | – | Placement | Completed | 6.6 | Medical devices and technology | Taylor Collison (lead manager) |
| Dec 2024 | Animalcare Group | – | – | Placement | Announced | 39.0 | Biotech and pharmaceuticals | Squire Patton Boggs (issuer) |
Deals come from ASX announcements, scheme booklets, prospectuses, the advisers' own deal announcements and the press. How the data is built